These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28557331)

  • 1. Understanding the Effect of Surface Chemistry of Mesoporous Silica Nanorods on Their Vaccine Adjuvant Potency.
    Yang Y; Jambhrunkar M; Abbaraju PL; Yu M; Zhang M; Yu C
    Adv Healthc Mater; 2017 Sep; 6(17):. PubMed ID: 28557331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic Mesoporous Silica Nanoparticle Adjuvants Modified with Binuclear Aluminum Complex: Coordination Chemistry Dictates Adjuvanticity.
    Yang Y; Tang J; Song H; Yang Y; Gu Z; Fu J; Liu Y; Zhang M; Qiao ZA; Yu C
    Angew Chem Int Ed Engl; 2020 Oct; 59(44):19610-19617. PubMed ID: 32876984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
    Mody KT; Popat A; Mahony D; Cavallaro AS; Yu C; Mitter N
    Nanoscale; 2013 Jun; 5(12):5167-79. PubMed ID: 23657437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice.
    Mahony D; Cavallaro AS; Stahr F; Mahony TJ; Qiao SZ; Mitter N
    Small; 2013 Sep; 9(18):3138-46. PubMed ID: 23625779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
    Nguyen TL; Choi Y; Kim J
    Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration.
    Li WA; Lu BY; Gu L; Choi Y; Kim J; Mooney DJ
    Biomaterials; 2016 Mar; 83():249-56. PubMed ID: 26784009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy.
    Lu Y; Yang Y; Gu Z; Zhang J; Song H; Xiang G; Yu C
    Biomaterials; 2018 Aug; 175():82-92. PubMed ID: 29803106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine.
    Lee JY; Kim MK; Nguyen TL; Kim J
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34658-34666. PubMed ID: 32662625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica particles potentiate antigen-specific T-cell responses.
    Kupferschmidt N; Qazi KR; Kemi C; Vallhov H; Garcia-Bennett AE; Gabrielsson S; Scheynius A
    Nanomedicine (Lond); 2014; 9(12):1835-46. PubMed ID: 25325240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses.
    Abbaraju PL; Jambhrunkar M; Yang Y; Liu Y; Lu Y; Yu C
    Chem Commun (Camb); 2018 Feb; 54(16):2020-2023. PubMed ID: 29411852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface PEGylation of Mesoporous Silica Nanorods (MSNR): Effect on loading, release, and delivery of mitoxantrone in hypoxic cancer cells.
    Wani A; Savithra GHL; Abyad A; Kanvinde S; Li J; Brock S; Oupický D
    Sci Rep; 2017 May; 7(1):2274. PubMed ID: 28536462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Si-doping increases the adjuvant activity of hydroxyapatite nanorods.
    Wang X; Ihara S; Li X; Ito A; Sogo Y; Watanabe Y; Tsuji NM; Yamazaki A
    Colloids Surf B Biointerfaces; 2019 Feb; 174():300-307. PubMed ID: 30469051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.
    Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G
    Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.
    Russell RF; McDonald JU; Lambert L; Tregoning JS
    J Virol; 2016 May; 90(9):4735-4744. PubMed ID: 26912628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy.
    Wang X; Li X; Ito A; Sogo Y; Ohno T
    J Biomed Mater Res A; 2014 Apr; 102(4):967-74. PubMed ID: 23650285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent Conjugation of Peptide Antigen to Mesoporous Silica Rods to Enhance Cellular Responses.
    Dellacherie MO; Li AW; Lu BY; Mooney DJ
    Bioconjug Chem; 2018 Mar; 29(3):733-741. PubMed ID: 29318872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant.
    Liu T; Liu H; Fu C; Li L; Chen D; Zhang Y; Tang F
    J Colloid Interface Sci; 2013 Jun; 400():168-74. PubMed ID: 23582904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
    Shima F; Akagi T; Uto T; Akashi M
    Biomaterials; 2013 Dec; 34(37):9709-16. PubMed ID: 24016848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants.
    Lu F; Mencia A; Bi L; Taylor A; Yao Y; HogenEsch H
    J Control Release; 2015 Apr; 204():51-9. PubMed ID: 25747143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.